MDS at SOHO 2022
A study showed "unexpected" results related to race and MDS survival...
Nearly a third (30%) of patients with higher-risk MDS have an overexpression of the RARA gene...
The classification process is mainly based on two processes, class discovery and class prediction...
Advertisement
Phillip Scheinberg, MD, PhD, discusses myelodysplastic syndromes at the 2022 SOHO Annual Meeting...
ASTX727 is an oral fixed-dose combination of HMA decitabine and cytidine deaminase inhibitor cedazuridine...
Blood Cancers Today interviewed Dr. Diez-Campelo after her presentation titled, “Treatment of Lower Risk MDS.”
Advertisement
Researchers retrospectively assessed 135 untreated patients with MDS who later developed HMA-F...
Lionel Adès, MD, PhD, spoke with Blood Cancers Today about the session he presented at the 2022 SOHO Annual Meeting...
The outcomes of AML transformation after HMA-failure MDS remain extremely poor...
Azacitidine is the current standard of care, and magrolimab is a monoclonal antibody blocking CD47 expression...
During the 2022 SOHO Annual Meeting, Jacqueline S. Garcia, MD, discussed immunotherapies for myelodysplastic syndromes...
There was no significant difference between patients treated with azacitidine on a five-day or a five-plus-two-day schedule..
Dr. Garcia-Manero talks about what a “total approach” to MDS means to him...
The number of HSCTs performed for MDS is increasing, yet HSCT remains under-utilized for MDS...
Guillermo Garcia-Manero, MD, was honored during the society’s 10th annual meeting in Houston, Texas...
The study sought to understand the characteristics and molecular profile of h-MDS in comparison with n-MDS...
Advertisement
Advertisement
Editorial Board
Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine
Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center
Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center
Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University
Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center
Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch
Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.